Adrenal Cortex NeoplasmsAdrenocortical CarcinomaATP Binding Cassette Transporter, Subfamily B
Dr. Brigitte C. Widemann, MD
NPI1407130362
- Publications
- 188
- Clinical trials
- 9
- Industry payments
- $1,436
- State license
- 1
- Year NPI issued
- 2011
- Practice address
- 8906 Bradmoor Dr, Bethesda, MD 20817-3457
- Practice phone
- Call (301) 496-7387
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Widemann's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Brigitte C. Widemann is a pediatric hematology and oncology physician in Bethesda, Maryland
Dr. Widemann practices in Bethesda, Maryland.
Dr. Widemann's NPI, 1407130362, was assigned on October 10, 2011. Dr. Widemann holds Maryland license D0054838.
NPI and contact details
- NPI
- 1407130362NPI Registry (opens in a new tab)
- NPI enumeration date
- October 10, 2011
- NPI status
- Active
- Practice phone
- (301) 496-7387
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Brigitte C. Widemann's practice address is in Bethesda, Maryland
Dr. Widemann's practice address in the NPI Registry is 8906 Bradmoor Dr, Bethesda, MD 20817-3457. The practice phone is (301) 496-7387.
- NPI Registry address8906 Bradmoor Dr, Bethesda, MD 20817-3457Phone(301) 496-7387
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Brigitte C. Widemann's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Widemann practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Widemann's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Widemann practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Brigitte C. Widemann is one of 62 pediatric hematologys and oncology physicians in Maryland
Pediatric hematology-oncology is Dr. Widemann's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Widemann is licensed in Maryland.
Specialties and state licenses
- Pediatric hematology and oncology, MarylandPrimary
Pediatric hematologys and oncology physicians near Dr. Widemann
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
62pediatric hematologys and oncology physicians in Maryland12pediatric hematologys and oncology physicians in Bethesda
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Brigitte C. Widemann has 188 publications on record
Dmand AI links 188 papers to Dr. Widemann, published from 2006 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Neurofibromatosis 1, Neurofibroma, Plexiform and Antineoplastic Agents. Dr. Widemann has published most often in Pediatr Blood Cancer. Dr. Widemann's most frequent co-authors are Jaishri O'Neill Blakeley, MD, John Glod, MD, PhD and Scott R. Plotkin, MD.
Papers188
Years published2006 to 2025
Dr. Widemann's papers by year, 2016 to 2025
Topics Dr. Widemann writes about most
- Neurofibromatosis 1
- Neurofibroma, Plexiform
- Antineoplastic Agents
- Magnetic Resonance Imaging
- Maximum Tolerated Dose
- Nerve Sheath Neoplasms
- Neurilemmoma
- Protein Kinase Inhibitors
Dr. Widemann's most frequent co-authors
- Jaishri O'Neill Blakeley, MD21 shared papers
- John Glod, MD, PhD20 shared papers
- Scott R. Plotkin, MD20 shared papers
Recent publications by Dr. Widemann
Antineoplastic Agents, ImmunologicalBevacizumabMagnetic Resonance Imaging
See who Dr. Widemann researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Widemann works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Brigitte C. Widemann has worked on 9 clinical trials
Dmand AI links Dr. Widemann to 9 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Neurofibromatosis 1, Astrocytoma and Central Nervous System Neoplasms. National Cancer Institute (NCI) sponsors the most, 6.
Clinical trials with Dr. Widemann by phase
- 2Phase 1: 2 trials
- 2Phase 1/2: 2 trials
- 3Phase 2: 3 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Widemann's trials
- Neurofibromatosis 1
- Astrocytoma
- Central Nervous System Neoplasms
- Chordoma
- Leukemia, Myelomonocytic, Juvenile
Investigators on the most trials with Dr. Widemann
- Julia L. Glade Bender, MD5 shared trials
- Ivan I. Kirov, MD4 shared trials
- James M. Croop, MD, PhD2 shared trials
Recent clinical trials with Dr. Widemann
Phase II Trial of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (opens in a new tab)
Active, not recruitingPhase 2
Neurofibroma, PlexiformNeurofibromatosis 1Selumetinib
Leukemia, Myelomonocytic, JuvenileBlast CrisisSorafenib Tosylate
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma (opens in a new tab)
CompletedPhase 2
Neurofibromatosis 1Optic Nerve GliomaSelumetinib Sulfate
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (opens in a new tab)
Active, not recruitingPhase 2
Sarcoma, Clear CellSarcoma, Alveolar Soft PartCabozantinibCabozantinib S-malate
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Brigitte C. Widemann received $1,436 in industry payments from 2017 to 2020
CMS Open Payments shows 13 general payments to Dr. Widemann from 1 drug or device company from 2017 to 2020. Travel and lodging make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,436.
General payments to Dr. Widemann by program year, 2017 to 2020
General payments to Dr. Widemann by kind, 2017 to 2020
$1.4Kin total
- Travel and lodging$1,23386%
- Food and beverage$20314%
Companies that paid Dr. Widemann the most, 2017 to 2020
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Brigitte C. Widemann's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Brigitte C. Widemann
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Brigitte C. Widemann's NPI number?
Dr. Brigitte C. Widemann's NPI number is 1407130362. It was assigned on October 10, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Brigitte C. Widemann?
Dr. Brigitte C. Widemann is a pediatric hematology and oncology physician in Bethesda, Maryland. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Brigitte C. Widemann practice?
Dr. Widemann practices at 8906 Bradmoor Dr, Bethesda, MD 20817-3457.
What is Dr. Brigitte C. Widemann's office phone number?
The practice phone on file for Dr. Widemann is (301) 496-7387.
What is Dr. Brigitte C. Widemann's medical license number?
Dr. Widemann holds Maryland license D0054838.
Has Dr. Brigitte C. Widemann received payments from drug or device companies?
CMS Open Payments shows $1,436 in general payments to Dr. Widemann from 1 company from 2017 to 2020. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Brigitte C. Widemann been practicing?
Dr. Widemann's NPI was assigned in 2011.
Does Dr. Brigitte C. Widemann do research?
Dmand AI links 188 publications to Dr. Widemann, published from 2006 to 2025. Dr. Widemann has worked on 9 clinical trials.
Who does Dr. Brigitte C. Widemann publish with?
Dr. Widemann's most frequent co-authors are Jaishri O'Neill Blakeley, MD (21 shared papers), John Glod, MD, PhD (20 shared papers) and Scott R. Plotkin, MD (20 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Maryland by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card